Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Blunted prolactin response to D-fenfluramine in post-stroke major depression
Philip Morris1, Malcolm Hopwood, Kay Maguire
1Gold Coast District Health Services, Integrated Mental Health Service, PO Box 554, Southport, Queensland 4215, Australia. philip_morris@health.qld.gov.au
Background:
This study investigated whether patients suffering from post-stroke depressive disorder had a similar disturbance in central serotonergic function to that described in non-brain injured depressed patients.
Methods:
Twenty-three depressed patients (nine major, 14 minor) and 38 non-depressed patients were examined 4-8 weeks post-stroke with a structured interview, rating scales and MRI brain scans. Patients were administered 30 mg D-fenfluramine orally and plasma prolactin and D-fenfluramine concentrations were measured for 6 h post-dose.
Results:
The prolactin response was significantly blunted in major depression compared to minor depression and non-depressed patients as measured by both delta prolactin and area under the prolactin versus time curve. There was no significant relationship between prolactin response and lesion lateralization or any of the measured clinical characteristics.
Limitations:
The major limitation of the study is the relatively small number in each depressive group.
Conclusions:
Patients suffering from major depression in the post-stroke period have a blunted prolactin response to D-fenfluramine. This indicates a serotonergic abnormality consistent with that found in major depression where neurological disease is not present.
Related Concept Videos
Stereotactic Injection of Hydrogel into a Post-Stroke Mouse Model
04:33Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
05:08Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits
05:19Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
04:38A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

